Skip to main content
Erschienen in: Skeletal Radiology 3/2023

23.05.2022 | Review Article

Paraneoplastic musculoskeletal disorders: review and update for radiologists

verfasst von: Kimia Khalatbari Kani, Jack A. Porrino, Michael E. Mulligan, Felix S. Chew

Erschienen in: Skeletal Radiology | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Abstract

Rheumatic paraneoplastic syndromes are rare syndromes that occur at distant sites from the underlying tumor and may involve the bones, joints, fasciae, muscles, or vessels. In the absence of a known tumor, early recognition of a rheumatic syndrome as paraneoplastic permits dedicated work-up for, and potentially early treatment of an occult malignancy. Although there is a continuously growing list of paraneoplastic rheumatic disorders, not all of these disorders have a well-established association with a neoplastic process. The goals of this article are to review the clinical characteristics, diagnostic work-up, and imaging findings of well-documented rheumatic paraneoplastic disorders.
Literatur
1.
Zurück zum Zitat Hashefi M. The relationship between rheumatologic disorders and malignancies. Rheum Dis Clin North Am. 2018;44(3):405–18.CrossRef Hashefi M. The relationship between rheumatologic disorders and malignancies. Rheum Dis Clin North Am. 2018;44(3):405–18.CrossRef
2.
Zurück zum Zitat Manger B, Schett G. Rheumatic paraneoplastic syndromes—a clinical link between malignancy and autoimmunity. Clin Immunol. 2018;186:67–70.CrossRef Manger B, Schett G. Rheumatic paraneoplastic syndromes—a clinical link between malignancy and autoimmunity. Clin Immunol. 2018;186:67–70.CrossRef
3.
Zurück zum Zitat Rennie JA, Auchterlonie IA. Rheumatological manifestations of the leukaemias and graft versus host disease. Baillieres Clin Rheumatol. 1991;5(2):231–51.CrossRef Rennie JA, Auchterlonie IA. Rheumatological manifestations of the leukaemias and graft versus host disease. Baillieres Clin Rheumatol. 1991;5(2):231–51.CrossRef
4.
Zurück zum Zitat Florenzano P, Hartley IR, Jimenez M, Roszko K, Gafni RI, Collins MT. Tumor-induced osteomalacia. Calcif Tissue Int. 2021;108(1):128–42.CrossRef Florenzano P, Hartley IR, Jimenez M, Roszko K, Gafni RI, Collins MT. Tumor-induced osteomalacia. Calcif Tissue Int. 2021;108(1):128–42.CrossRef
5.
Zurück zum Zitat Folpe AL. Phosphaturic mesenchymal tumors: a review and update. Semin Diagn Pathol. 2019;36(4):260–8.CrossRef Folpe AL. Phosphaturic mesenchymal tumors: a review and update. Semin Diagn Pathol. 2019;36(4):260–8.CrossRef
6.
Zurück zum Zitat Li X, Jiang Y, Huo L, et al. Nonremission and recurrent tumor-induced osteomalacia: a retrospective study. J Bone Miner Res. 2020;35(3):469–77.CrossRef Li X, Jiang Y, Huo L, et al. Nonremission and recurrent tumor-induced osteomalacia: a retrospective study. J Bone Miner Res. 2020;35(3):469–77.CrossRef
7.
Zurück zum Zitat ADHR Consortium. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet. 2000;26(3):345–8.CrossRef ADHR Consortium. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet. 2000;26(3):345–8.CrossRef
8.
Zurück zum Zitat Riminucci M, Collins MT, Fedarko NS, et al. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest. 2003;112(5):683–92.CrossRef Riminucci M, Collins MT, Fedarko NS, et al. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest. 2003;112(5):683–92.CrossRef
9.
Zurück zum Zitat Endo I, Fukumoto S, Ozono K, et al. Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment. Endocr J. 2015;62(9):811–6.CrossRef Endo I, Fukumoto S, Ozono K, et al. Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment. Endocr J. 2015;62(9):811–6.CrossRef
10.
Zurück zum Zitat Feng J, Jiang Y, Wang O, et al. The diagnostic dilemma of tumor induced osteomalacia: a retrospective analysis of 144 cases. Endocr J. 2017;64(7):675–83.CrossRef Feng J, Jiang Y, Wang O, et al. The diagnostic dilemma of tumor induced osteomalacia: a retrospective analysis of 144 cases. Endocr J. 2017;64(7):675–83.CrossRef
11.
Zurück zum Zitat Chong WH, Molinolo AA, Chen CC, Collins MT. Tumor-induced osteomalacia. Endocr Relat Cancer. 2011;18(3):R53-77.CrossRef Chong WH, Molinolo AA, Chen CC, Collins MT. Tumor-induced osteomalacia. Endocr Relat Cancer. 2011;18(3):R53-77.CrossRef
12.
Zurück zum Zitat Broski SM, Folpe AL, Wenger DE. Imaging features of phosphaturic mesenchymal tumors. Skeletal Radiol. 2019;48(1):119–27.CrossRef Broski SM, Folpe AL, Wenger DE. Imaging features of phosphaturic mesenchymal tumors. Skeletal Radiol. 2019;48(1):119–27.CrossRef
13.
Zurück zum Zitat Reubi JC, Waser B, Schaer JC, Laissue JA. Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands. Eur J Nucl Med. 2001;28(7):836–46.CrossRef Reubi JC, Waser B, Schaer JC, Laissue JA. Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands. Eur J Nucl Med. 2001;28(7):836–46.CrossRef
14.
Zurück zum Zitat Rayamajhi SJ, Yeh R, Wong T, et al. Tumor-induced osteomalacia—current imaging modalities and a systematic approach for tumor localization. Clin Imaging. 2019;56:114–23.CrossRef Rayamajhi SJ, Yeh R, Wong T, et al. Tumor-induced osteomalacia—current imaging modalities and a systematic approach for tumor localization. Clin Imaging. 2019;56:114–23.CrossRef
15.
Zurück zum Zitat Jing H, Li F, Zhuang H, et al. Effective detection of the tumors causing osteomalacia using [Tc-99m]-HYNIC-octreotide (99mTc-HYNIC-TOC) whole body scan. Eur J Radiol. 2013;82(11):2028–34.CrossRef Jing H, Li F, Zhuang H, et al. Effective detection of the tumors causing osteomalacia using [Tc-99m]-HYNIC-octreotide (99mTc-HYNIC-TOC) whole body scan. Eur J Radiol. 2013;82(11):2028–34.CrossRef
16.
Zurück zum Zitat Houang M, Clarkson A, Sioson L, et al. Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A). Hum Pathol. 2013;44(12):2711–8.CrossRef Houang M, Clarkson A, Sioson L, et al. Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A). Hum Pathol. 2013;44(12):2711–8.CrossRef
17.
Zurück zum Zitat Zhang J, Zhu Z, Zhong D, et al. 68Ga DOTATATE PET/CT is an accurate imaging modality in the detection of culprit tumors causing osteomalacia. Clin Nucl Med. 2015;40(8):642–6.CrossRef Zhang J, Zhu Z, Zhong D, et al. 68Ga DOTATATE PET/CT is an accurate imaging modality in the detection of culprit tumors causing osteomalacia. Clin Nucl Med. 2015;40(8):642–6.CrossRef
18.
Zurück zum Zitat Bhavani N, Reena Asirvatham A, Kallur K, et al. Utility of Gallium-68 DOTANOC PET/CT in the localization of tumour-induced osteomalacia. Clin Endocrinol (Oxf). 2016;84(1):134–40.CrossRef Bhavani N, Reena Asirvatham A, Kallur K, et al. Utility of Gallium-68 DOTANOC PET/CT in the localization of tumour-induced osteomalacia. Clin Endocrinol (Oxf). 2016;84(1):134–40.CrossRef
19.
Zurück zum Zitat Yu WJ, He JW, Fu WZ, Wang C, Zhang ZL. Reports of 17 Chinese patients with tumor-induced osteomalacia. J Bone Miner Metab. 2017;35(3):298–307.CrossRef Yu WJ, He JW, Fu WZ, Wang C, Zhang ZL. Reports of 17 Chinese patients with tumor-induced osteomalacia. J Bone Miner Metab. 2017;35(3):298–307.CrossRef
20.
Zurück zum Zitat Jiang Y, Xia WB, Xing XP, et al. Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: Report of 39 cases and review of the literature. J Bone Miner Res. 2012;27(9):1967–75.CrossRef Jiang Y, Xia WB, Xing XP, et al. Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: Report of 39 cases and review of the literature. J Bone Miner Res. 2012;27(9):1967–75.CrossRef
21.
Zurück zum Zitat Avila NA, Skarulis M, Rubino DM, Doppman JL. Oncogenic osteomalacia: lesion detection by MR skeletal survey. AJR Am J Roentgenol. 1996;167(2):343–5.CrossRef Avila NA, Skarulis M, Rubino DM, Doppman JL. Oncogenic osteomalacia: lesion detection by MR skeletal survey. AJR Am J Roentgenol. 1996;167(2):343–5.CrossRef
22.
Zurück zum Zitat Ashton C, Paramalingam S, Stevenson B, Brusch A, Needham M. Idiopathic inflammatory myopathies: a review. Intern Med J. 2021;51(6):845–52.CrossRef Ashton C, Paramalingam S, Stevenson B, Brusch A, Needham M. Idiopathic inflammatory myopathies: a review. Intern Med J. 2021;51(6):845–52.CrossRef
23.
Zurück zum Zitat Tiniakou E, Mammen AL. Idiopathic inflammatory myopathies and malignancy: a comprehensive review. Clin Rev Allergy Immunol. 2017;52(1):20–33.CrossRef Tiniakou E, Mammen AL. Idiopathic inflammatory myopathies and malignancy: a comprehensive review. Clin Rev Allergy Immunol. 2017;52(1):20–33.CrossRef
24.
Zurück zum Zitat Yang Z, Lin F, Qin B, Liang Y, Zhong R. Polymyositis/dermatomyositis and malignancy risk: a metaanalysis study. J Rheumatol. 2015;42(2):282–91.CrossRef Yang Z, Lin F, Qin B, Liang Y, Zhong R. Polymyositis/dermatomyositis and malignancy risk: a metaanalysis study. J Rheumatol. 2015;42(2):282–91.CrossRef
25.
Zurück zum Zitat Moghadam-Kia S, Oddis CV, Ascherman DP, Aggarwal R. Risk factors and cancer screening in myositis. Rheum Dis Clin North Am. 2020;46(3):565–76.CrossRef Moghadam-Kia S, Oddis CV, Ascherman DP, Aggarwal R. Risk factors and cancer screening in myositis. Rheum Dis Clin North Am. 2020;46(3):565–76.CrossRef
26.
Zurück zum Zitat Kang EH, Lee SJ, Ascherman DP, et al. Temporal relationship between cancer and myositis identifies two distinctive subgroups of cancers: impact on cancer risk and survival in patients with myositis. Rheumatology (Oxford). 2016;55(9):1631–41.CrossRef Kang EH, Lee SJ, Ascherman DP, et al. Temporal relationship between cancer and myositis identifies two distinctive subgroups of cancers: impact on cancer risk and survival in patients with myositis. Rheumatology (Oxford). 2016;55(9):1631–41.CrossRef
27.
Zurück zum Zitat Manger B, Schett G. Paraneoplastic syndromes in rheumatology. Nat Rev Rheumatol. 2014;10(11):662–70.CrossRef Manger B, Schett G. Paraneoplastic syndromes in rheumatology. Nat Rev Rheumatol. 2014;10(11):662–70.CrossRef
28.
Zurück zum Zitat Qiang JK, Kim WB, Baibergenova A, Alhusayen R. Risk of malignancy in dermatomyositis and polymyositis. J Cutan Med Surg. 2017;21(2):131–6.CrossRef Qiang JK, Kim WB, Baibergenova A, Alhusayen R. Risk of malignancy in dermatomyositis and polymyositis. J Cutan Med Surg. 2017;21(2):131–6.CrossRef
29.
Zurück zum Zitat Ichimura Y, Matsushita T, Hamaguchi Y, et al. Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy. Ann Rheum Dis. 2012;71(5):710–3.CrossRef Ichimura Y, Matsushita T, Hamaguchi Y, et al. Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy. Ann Rheum Dis. 2012;71(5):710–3.CrossRef
30.
Zurück zum Zitat Kaji K, Fujimoto M, Hasegawa M, et al. Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. Rheumatology (Oxford). 2007;46(1):25–8.CrossRef Kaji K, Fujimoto M, Hasegawa M, et al. Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. Rheumatology (Oxford). 2007;46(1):25–8.CrossRef
31.
Zurück zum Zitat Targoff IN, Mamyrova G, Trieu EP, et al. A novel autoantibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum. 2006;54(11):3682–9.CrossRef Targoff IN, Mamyrova G, Trieu EP, et al. A novel autoantibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum. 2006;54(11):3682–9.CrossRef
32.
Zurück zum Zitat Fayyaz B, Rehman HJ, Uqdah H. Cancer-associated myositis: an elusive entity. J Community Hosp Intern Med Perspect. 92019. p. 45–9. Fayyaz B, Rehman HJ, Uqdah H. Cancer-associated myositis: an elusive entity. J Community Hosp Intern Med Perspect. 92019. p. 45–9.
33.
Zurück zum Zitat Owada T, Maezawa R, Kurasawa K, Okada H, Arai S, Fukuda T. Detection of inflammatory lesions by f-18 fluorodeoxyglucose positron emission tomography in patients with polymyositis and dermatomyositis. J Rheumatol. 2012;39(8):1659–65.CrossRef Owada T, Maezawa R, Kurasawa K, Okada H, Arai S, Fukuda T. Detection of inflammatory lesions by f-18 fluorodeoxyglucose positron emission tomography in patients with polymyositis and dermatomyositis. J Rheumatol. 2012;39(8):1659–65.CrossRef
34.
Zurück zum Zitat András C, Ponyi A, Constantin T, et al. Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study. J Rheumatol. 2008;35(3):438–44. András C, Ponyi A, Constantin T, et al. Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study. J Rheumatol. 2008;35(3):438–44.
35.
Zurück zum Zitat Callemeyn J, Van Haecke P, Peetermans WE, Blockmans D. Clubbing and hypertrophic osteoarthropathy: insights in diagnosis, pathophysiology, and clinical significance. Acta Clin Belg. 2016;71(3):123–30.CrossRef Callemeyn J, Van Haecke P, Peetermans WE, Blockmans D. Clubbing and hypertrophic osteoarthropathy: insights in diagnosis, pathophysiology, and clinical significance. Acta Clin Belg. 2016;71(3):123–30.CrossRef
36.
Zurück zum Zitat Krugh M, Vaidya PN. Osteoarthropathy hypertrophic. StatPearls. Treasure Island (FL): StatPearls PublishingCopyright © 2021. Krugh M, Vaidya PN. Osteoarthropathy hypertrophic. StatPearls. Treasure Island (FL): StatPearls PublishingCopyright © 2021.
37.
Zurück zum Zitat Yap FY, Skalski MR, Patel DB, et al. Hypertrophic osteoarthropathy: clinical and imaging Features. Radiographics. 2017;37(1):157–95.CrossRef Yap FY, Skalski MR, Patel DB, et al. Hypertrophic osteoarthropathy: clinical and imaging Features. Radiographics. 2017;37(1):157–95.CrossRef
38.
Zurück zum Zitat Yao Q, Altman RD, Brahn E. Periostitis and hypertrophic pulmonary osteoarthropathy: report of 2 cases and review of the literature. Semin Arthritis Rheum. 2009;38(6):458–66.CrossRef Yao Q, Altman RD, Brahn E. Periostitis and hypertrophic pulmonary osteoarthropathy: report of 2 cases and review of the literature. Semin Arthritis Rheum. 2009;38(6):458–66.CrossRef
39.
Zurück zum Zitat Smets P, Devauchelle-Pensec V, Rouzaire PO, Pereira B, Andre M, Soubrier M. Vascular endothelial growth factor levels and rheumatic diseases of the elderly. Arthritis Res Ther. 2016;18(1):283.CrossRef Smets P, Devauchelle-Pensec V, Rouzaire PO, Pereira B, Andre M, Soubrier M. Vascular endothelial growth factor levels and rheumatic diseases of the elderly. Arthritis Res Ther. 2016;18(1):283.CrossRef
40.
Zurück zum Zitat Vandemergel X, Blocklet D, Decaux G. Periostitis and hypertrophic osteoarthropathy: etiologies and bone scan patterns in 115 cases. Eur J Intern Med. 2004;15(6):375–80.CrossRef Vandemergel X, Blocklet D, Decaux G. Periostitis and hypertrophic osteoarthropathy: etiologies and bone scan patterns in 115 cases. Eur J Intern Med. 2004;15(6):375–80.CrossRef
41.
Zurück zum Zitat Izumi M, Takayama K, Yabuuchi H, Abe K, Nakanishi Y. Incidence of hypertrophic pulmonary osteoarthropathy associated with primary lung cancer. Respirology. 2010;15(5):809–12.CrossRef Izumi M, Takayama K, Yabuuchi H, Abe K, Nakanishi Y. Incidence of hypertrophic pulmonary osteoarthropathy associated with primary lung cancer. Respirology. 2010;15(5):809–12.CrossRef
42.
Zurück zum Zitat Abdel-Hamid MZ, Chang CH, Chan YS, et al. Arthroscopic evaluation of soft tissue injuries in tibial plateau fractures: retrospective analysis of 98 cases. Arthroscopy. 2006;22(6):669–75.CrossRef Abdel-Hamid MZ, Chang CH, Chan YS, et al. Arthroscopic evaluation of soft tissue injuries in tibial plateau fractures: retrospective analysis of 98 cases. Arthroscopy. 2006;22(6):669–75.CrossRef
43.
Zurück zum Zitat Pineda C, Martínez-Lavín M. Hypertrophic osteoarthropathy: what a rheumatologist should know about this uncommon condition. Rheum Dis Clin North Am. 2013;39(2):383–400.CrossRef Pineda C, Martínez-Lavín M. Hypertrophic osteoarthropathy: what a rheumatologist should know about this uncommon condition. Rheum Dis Clin North Am. 2013;39(2):383–400.CrossRef
44.
Zurück zum Zitat Russo RR, Lee A, Mansberg R, Emmett L. Hypertrophic pulmonary osteoarthropathy demonstrated on SPECT/CT. Clin Nucl Med. 2009;34(9):628–31.CrossRef Russo RR, Lee A, Mansberg R, Emmett L. Hypertrophic pulmonary osteoarthropathy demonstrated on SPECT/CT. Clin Nucl Med. 2009;34(9):628–31.CrossRef
45.
Zurück zum Zitat Shih WJ. Pulmonary hypertrophic osteoarthropathy and its resolution. Semin Nucl Med. 2004;34(2):159–63.CrossRef Shih WJ. Pulmonary hypertrophic osteoarthropathy and its resolution. Semin Nucl Med. 2004;34(2):159–63.CrossRef
46.
Zurück zum Zitat Capelastegui A, Astigarraga E, García-Iturraspe C. MR findings in pulmonary hypertrophic osteoarthropathy. Clin Radiol. 2000;55(1):72–5.CrossRef Capelastegui A, Astigarraga E, García-Iturraspe C. MR findings in pulmonary hypertrophic osteoarthropathy. Clin Radiol. 2000;55(1):72–5.CrossRef
47.
Zurück zum Zitat Chakraborty RK, Sharma S. Secondary hypertrophic osteoarthropathy. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2021. Chakraborty RK, Sharma S. Secondary hypertrophic osteoarthropathy. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2021.
48.
Zurück zum Zitat Pines A, Kaplinsky N, Olchovsky D, Frankl O. Rheumatoid arthritis-like syndrome: a presenting symptom of malignancy. Report of 3 cases and review of the literature. Eur J Rheumatol Inflamm. 1984;7(2):51–5. Pines A, Kaplinsky N, Olchovsky D, Frankl O. Rheumatoid arthritis-like syndrome: a presenting symptom of malignancy. Report of 3 cases and review of the literature. Eur J Rheumatol Inflamm. 1984;7(2):51–5.
49.
Zurück zum Zitat Khan F, Kleppel H, Meara A. Paraneoplastic musculoskeletal syndromes. Rheum Dis Clin North Am. 2020;46(3):577–86.CrossRef Khan F, Kleppel H, Meara A. Paraneoplastic musculoskeletal syndromes. Rheum Dis Clin North Am. 2020;46(3):577–86.CrossRef
50.
Zurück zum Zitat Schultz H, Krenn V, Tony HP. Oligoarthritis mediated by tumor-specific T lymphocytes in renal-cell carcinoma. N Engl J Med. 1999;341(4):290–1.CrossRef Schultz H, Krenn V, Tony HP. Oligoarthritis mediated by tumor-specific T lymphocytes in renal-cell carcinoma. N Engl J Med. 1999;341(4):290–1.CrossRef
51.
Zurück zum Zitat Parperis K, Constantinidou A, Panos G. Paraneoplastic arthritides: insights to pathogenesis, diagnostic approach, and treatment. J Clin Rheumatol. 2021;27(8):e505–9.CrossRef Parperis K, Constantinidou A, Panos G. Paraneoplastic arthritides: insights to pathogenesis, diagnostic approach, and treatment. J Clin Rheumatol. 2021;27(8):e505–9.CrossRef
52.
Zurück zum Zitat Kisacik B, Onat AM, Kasifoglu T, et al. Diagnostic dilemma of paraneoplastic arthritis: case series. Int J Rheum Dis. 2014;17(6):640–5.CrossRef Kisacik B, Onat AM, Kasifoglu T, et al. Diagnostic dilemma of paraneoplastic arthritis: case series. Int J Rheum Dis. 2014;17(6):640–5.CrossRef
53.
Zurück zum Zitat Hakkou J, Rostom S, Bahiri R, Hajjaj-Hassouni N. Paraneoplastic rheumatic syndromes: report of eight cases and review of literature. Rheumatol Int. 2012;32(6):1485–9.CrossRef Hakkou J, Rostom S, Bahiri R, Hajjaj-Hassouni N. Paraneoplastic rheumatic syndromes: report of eight cases and review of literature. Rheumatol Int. 2012;32(6):1485–9.CrossRef
54.
Zurück zum Zitat McCarty DJ, O’Duffy JD, Pearson L, Hunter JB. Remitting seronegative symmetrical synovitis with pitting edema. RS3PE syndrome. Jama. 1985;254(19):2763–7.CrossRef McCarty DJ, O’Duffy JD, Pearson L, Hunter JB. Remitting seronegative symmetrical synovitis with pitting edema. RS3PE syndrome. Jama. 1985;254(19):2763–7.CrossRef
55.
Zurück zum Zitat Lakhmalla M, Dahiya DS, Kichloo A, Fatima T, Edigin E, Wani F. Remitting seronegative symmetrical synovitis with pitting edema: a review. J Investig Med. 2021;69(1):86–90.CrossRef Lakhmalla M, Dahiya DS, Kichloo A, Fatima T, Edigin E, Wani F. Remitting seronegative symmetrical synovitis with pitting edema: a review. J Investig Med. 2021;69(1):86–90.CrossRef
56.
Zurück zum Zitat Origuchi T, Arima K, Kawashiri SY, et al. High serum matrix metalloproteinase 3 is characteristic of patients with paraneoplastic remitting seronegative symmetrical synovitis with pitting edema syndrome. Mod Rheumatol. 2012;22(4):584–8.CrossRef Origuchi T, Arima K, Kawashiri SY, et al. High serum matrix metalloproteinase 3 is characteristic of patients with paraneoplastic remitting seronegative symmetrical synovitis with pitting edema syndrome. Mod Rheumatol. 2012;22(4):584–8.CrossRef
57.
Zurück zum Zitat Kawashiri SY, Suzuki T, Okada A, et al. Differences in musculoskeletal ultrasound findings between RS3PE syndrome and elderly-onset rheumatoid arthritis. Clin Rheumatol. 2020;39(6):1981–8.CrossRef Kawashiri SY, Suzuki T, Okada A, et al. Differences in musculoskeletal ultrasound findings between RS3PE syndrome and elderly-onset rheumatoid arthritis. Clin Rheumatol. 2020;39(6):1981–8.CrossRef
58.
Zurück zum Zitat Unlu Z, Orguc S, Ovali GY, Tarhan S, Dayan I, Angin A. Magnetic resonance imaging findings in a case of remitting seronegative symmetrical synovitis with pitting edema. Clin Rheumatol. 2005;24(6):648–51.CrossRef Unlu Z, Orguc S, Ovali GY, Tarhan S, Dayan I, Angin A. Magnetic resonance imaging findings in a case of remitting seronegative symmetrical synovitis with pitting edema. Clin Rheumatol. 2005;24(6):648–51.CrossRef
59.
Zurück zum Zitat Hotta M, Minamimoto R, Kaneko H, Yamashita H. Fluorodeoxyglucose PET/CT of arthritis in rheumatic diseases: a pictorial review. Radiographics. 2020;40(1):223–40.CrossRef Hotta M, Minamimoto R, Kaneko H, Yamashita H. Fluorodeoxyglucose PET/CT of arthritis in rheumatic diseases: a pictorial review. Radiographics. 2020;40(1):223–40.CrossRef
60.
Zurück zum Zitat Wang J, Pu C, Wang Z, Yang J. Remitting seronegative symmetrical synovitis with pitting edema: appearance on FDG PET/CT. Clin Nucl Med. 2017;42(6):492–5.CrossRef Wang J, Pu C, Wang Z, Yang J. Remitting seronegative symmetrical synovitis with pitting edema: appearance on FDG PET/CT. Clin Nucl Med. 2017;42(6):492–5.CrossRef
61.
Zurück zum Zitat Medsger TA, Dixon JA, Garwood VF. Palmar fasciitis and polyarthritis associated with ovarian carcinoma. Ann Intern Med. 1982;96(4):424–31.CrossRef Medsger TA, Dixon JA, Garwood VF. Palmar fasciitis and polyarthritis associated with ovarian carcinoma. Ann Intern Med. 1982;96(4):424–31.CrossRef
62.
Zurück zum Zitat Manger B, Schett G. Palmar fasciitis and polyarthritis syndrome-systematic literature review of 100 cases. Semin Arthritis Rheum. 2014;44(1):105–11.CrossRef Manger B, Schett G. Palmar fasciitis and polyarthritis syndrome-systematic literature review of 100 cases. Semin Arthritis Rheum. 2014;44(1):105–11.CrossRef
63.
Zurück zum Zitat Yoshioka K, Fukumoto T, Sowa-Osako J, Tateishi C. Idiopathic palmar fasciitis and polyarthritis syndrome. BMJ Case Rep. 2019;12(11):e232954. Yoshioka K, Fukumoto T, Sowa-Osako J, Tateishi C. Idiopathic palmar fasciitis and polyarthritis syndrome. BMJ Case Rep. 2019;12(11):e232954.
64.
Zurück zum Zitat Celen H, Neerinckx B. Palmar fasciitis and polyarthritis: an uncommon but remarkable paraneoplastic syndrome. Clin Rheumatol. 40. Germany2021. p. 2507–8. Celen H, Neerinckx B. Palmar fasciitis and polyarthritis: an uncommon but remarkable paraneoplastic syndrome. Clin Rheumatol. 40. Germany2021. p. 2507–8.
65.
Zurück zum Zitat Salmon C, Gill G, Loeuille D, Chary-Valckenaere I. Three new cases of palmar fasciitis with polyarthritis including a patient with atypical mutilating osteolysis. Joint Bone Spine. 2013;80(2):217–20.CrossRef Salmon C, Gill G, Loeuille D, Chary-Valckenaere I. Three new cases of palmar fasciitis with polyarthritis including a patient with atypical mutilating osteolysis. Joint Bone Spine. 2013;80(2):217–20.CrossRef
66.
Zurück zum Zitat Qureshi AA, Saavedra A. Palmar fasciitis and polyarthritis syndrome in patients with ovarian cancer-a case report and review of the literature. Hand (N Y). 2011;6(2):220–3.CrossRef Qureshi AA, Saavedra A. Palmar fasciitis and polyarthritis syndrome in patients with ovarian cancer-a case report and review of the literature. Hand (N Y). 2011;6(2):220–3.CrossRef
67.
Zurück zum Zitat Betrains A, Rosseels W, Van Mieghem E, Vanderschueren S, Nijs J. Clinical characteristics, treatment, and outcome of pancreatitis, panniculitis, and polyarthritis syndrome: a case-based review. Clin Rheumatol. 2021;40(4):1625–33.CrossRef Betrains A, Rosseels W, Van Mieghem E, Vanderschueren S, Nijs J. Clinical characteristics, treatment, and outcome of pancreatitis, panniculitis, and polyarthritis syndrome: a case-based review. Clin Rheumatol. 2021;40(4):1625–33.CrossRef
68.
Zurück zum Zitat Yasuda MR, Roller LA, Fagenholz PJ, Hoang MP. Case 33–2020: A 55-year-old man with abdominal pain, joint swelling, and skin lesions. N Engl J Med. 2020;383(17):1664–71.CrossRef Yasuda MR, Roller LA, Fagenholz PJ, Hoang MP. Case 33–2020: A 55-year-old man with abdominal pain, joint swelling, and skin lesions. N Engl J Med. 2020;383(17):1664–71.CrossRef
69.
Zurück zum Zitat Narváez J, Bianchi MM, Santo P, et al. Pancreatitis, panniculitis, and polyarthritis. Semin Arthritis Rheum. 2010;39(5):417–23.CrossRef Narváez J, Bianchi MM, Santo P, et al. Pancreatitis, panniculitis, and polyarthritis. Semin Arthritis Rheum. 2010;39(5):417–23.CrossRef
70.
Zurück zum Zitat Ahn BC, Lee J, Suh KJ, et al. Intramedullary fat necrosis of multiple bones associated with pancreatitis. J Nucl Med. 1998;39(8):1401–4. Ahn BC, Lee J, Suh KJ, et al. Intramedullary fat necrosis of multiple bones associated with pancreatitis. J Nucl Med. 1998;39(8):1401–4.
71.
Zurück zum Zitat Immelman EJ, Bank S, Krige H, Marks IN. Roentgenologic and clinical features of intramedullary fat necrosis in bones in acute and chronic pancreatitis. Am J Med. 1964;36:96–105.CrossRef Immelman EJ, Bank S, Krige H, Marks IN. Roentgenologic and clinical features of intramedullary fat necrosis in bones in acute and chronic pancreatitis. Am J Med. 1964;36:96–105.CrossRef
72.
Zurück zum Zitat Tupalli A, Angamuthu M, Prashanth A, Singh R, Kumar R. Intraosseous medullary fat necrosis on 99mTc-MDP bone scan of patient with acute pancreatitis. Clin Nucl Med. 2020;45(6):e294–5.CrossRef Tupalli A, Angamuthu M, Prashanth A, Singh R, Kumar R. Intraosseous medullary fat necrosis on 99mTc-MDP bone scan of patient with acute pancreatitis. Clin Nucl Med. 2020;45(6):e294–5.CrossRef
73.
Zurück zum Zitat Kang DJ, Lee SJ, Choo HJ, Her M, Yoon HK. Pancreatitis, panniculitis, and polyarthritis (PPP) syndrome: MRI features of intraosseous fat necrosis involving the feet and knees. Skeletal Radiol. 2017;46(2):279–85.CrossRef Kang DJ, Lee SJ, Choo HJ, Her M, Yoon HK. Pancreatitis, panniculitis, and polyarthritis (PPP) syndrome: MRI features of intraosseous fat necrosis involving the feet and knees. Skeletal Radiol. 2017;46(2):279–85.CrossRef
74.
Zurück zum Zitat Karasick D, Schweitzer ME. Case 4: intraosseous fat necrosis associated with pancreatitis. Radiology. 1998;209(2):521–4.CrossRef Karasick D, Schweitzer ME. Case 4: intraosseous fat necrosis associated with pancreatitis. Radiology. 1998;209(2):521–4.CrossRef
75.
Zurück zum Zitat Dickerson LK, Sullivan KM, Chew FS, et al. A surgeon, a dermatologist, and a rheumatologist walk into a bar: pancreatitis, panniculitis, and polyarthritis (PPP) syndrome and the role of surgery in a systemic disease. ACS Case Reviews in Surgery. Publication in Press (per personal communication with Felix Chew, MD). Dickerson LK, Sullivan KM, Chew FS, et al. A surgeon, a dermatologist, and a rheumatologist walk into a bar: pancreatitis, panniculitis, and polyarthritis (PPP) syndrome and the role of surgery in a systemic disease. ACS Case Reviews in Surgery. Publication in Press (per personal communication with Felix Chew, MD).
76.
Zurück zum Zitat Park HJ, Ranganathan P. Neoplastic and paraneoplastic vasculitis, vasculopathy, and hypercoagulability. Rheum Dis Clin North Am. 2011;37(4):593–606.CrossRef Park HJ, Ranganathan P. Neoplastic and paraneoplastic vasculitis, vasculopathy, and hypercoagulability. Rheum Dis Clin North Am. 2011;37(4):593–606.CrossRef
77.
Zurück zum Zitat Loricera J, Calvo-Río V, Ortiz-Sanjuán F, et al. The spectrum of paraneoplastic cutaneous vasculitis in a defined population: incidence and clinical features. Medicine (Baltimore). 2013;92(6):331–43.CrossRef Loricera J, Calvo-Río V, Ortiz-Sanjuán F, et al. The spectrum of paraneoplastic cutaneous vasculitis in a defined population: incidence and clinical features. Medicine (Baltimore). 2013;92(6):331–43.CrossRef
79.
Zurück zum Zitat Dylewski J, Luterman L. Septic arthritis and Clostridium septicum: a clue to colon cancer. CMAJ. 2010;182(13):1446–7.CrossRef Dylewski J, Luterman L. Septic arthritis and Clostridium septicum: a clue to colon cancer. CMAJ. 2010;182(13):1446–7.CrossRef
80.
Zurück zum Zitat García-Porrúa C, González-Gay MA, Monterroso JR, Sánchez-Andrade A, González-Ramirez A. Septic arthritis due to Streptococcus bovis as presenting sign of “silent” colon carcinoma. Rheumatology (Oxford). 2000;39(3):338–9.CrossRef García-Porrúa C, González-Gay MA, Monterroso JR, Sánchez-Andrade A, González-Ramirez A. Septic arthritis due to Streptococcus bovis as presenting sign of “silent” colon carcinoma. Rheumatology (Oxford). 2000;39(3):338–9.CrossRef
81.
Zurück zum Zitat Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58(5):295–300. Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58(5):295–300.
Metadaten
Titel
Paraneoplastic musculoskeletal disorders: review and update for radiologists
verfasst von
Kimia Khalatbari Kani
Jack A. Porrino
Michael E. Mulligan
Felix S. Chew
Publikationsdatum
23.05.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
Skeletal Radiology / Ausgabe 3/2023
Print ISSN: 0364-2348
Elektronische ISSN: 1432-2161
DOI
https://doi.org/10.1007/s00256-022-04074-w

Weitere Artikel der Ausgabe 3/2023

Skeletal Radiology 3/2023 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.